SCHEMBL1490439

SCHEMBL1490439

Cc1cccc(C(=O)Nc2csc(-c3ccc(Cl)cc3)c2C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.53
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
KCNK3 O14649 3/20 0.52
KMT2A Q03164 7/20 0.50
MEN1 O00255 6/20 0.50
ALDH1A1 P00352 3/20 0.49
GFER P55789 2/20 0.49
GPR35 Q9HC97 2/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
SUCNR1 Q9BXA5 1/20 0.48
KCNK9 Q9NPC2 2/20 0.47
MAPT P10636 4/20 0.47
TP53 P04637 2/20 0.47
NPC1 O15118 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HDAC2 Q92769 1/20 0.46
ANO1 Q5XXA6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490591 0.92 CASP3 (0.55) CASP3SENP8SENP7SENP6KCNK3
SCHEMBL1490226 0.91 MEN1 (0.58) CASP3SENP8SENP7SENP6KCNK3
SCHEMBL1490574 0.90 KCNK3 (0.52) CASP3SENP8SENP7SENP6KCNK3
SCHEMBL12830927 0.90 KCNMA1 (0.52) KCNK3KMT2AMEN1SUCNR1KCNK9
SCHEMBL1490714 0.89 CASP3 (0.53) CASP3SENP8SENP7SENP6KCNK3
SCHEMBL1490272 0.89 CASP3 (0.67) CASP3SENP8SENP7SENP6KCNK3
SCHEMBL12756545 0.87 ANO1 (0.49) KMT2AMEN1ALDH1A1LMNAHPGD
SCHEMBL12830941 0.87 GRIK1 (0.58) CASP3SENP8SENP7SENP6KMT2A
SCHEMBL1490500 0.87 MEN1 (0.50) KCNK3KMT2AMEN1ALDH1A1SUCNR1
SCHEMBL1490668 0.87 CASP3 (0.53) CASP3SENP8SENP7SENP6KCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 EP disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CASP3 2232/4885SENP8 3756/4885SENP7 3940/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CASP3 2232/4885SENP8 3756/4885SENP7 3940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.